What question did this study set out to answer?

This research aims to identify factors predictive of long-term use of anamorelin hydrochloride in cancer cachexia patients.

March 25, 2026

Predictors of long-term anamorelin hydrochloride use in patients with cancer cachexia: a single-center real-world retrospective study

Key Points

This research aims to identify factors predictive of long-term use of anamorelin hydrochloride in cancer cachexia patients.
Conducted a retrospective analysis at a single center
Evaluated association between mGPS, ECOG PS, and anamorelin duration
Included patients diagnosed with cancer cachexia
Lower mGPS scores associated with longer anamorelin use
Better ECOG PS correlated with prolonged treatment duration
Patients with gastric cancer showed a tendency for shorter anamorelin use

Abstract

Lower mGPS, and better ECOG PS were associated with longer continuation of anamorelin, whereas patients with gastric cancer showed a tendency toward shorter duration. These findings provide guidance for patient selection and tailored supportive care in clinical practice.

Predictors of long-term anamorelin hydrochloride use in patients with cancer cachexia: a single-center real-world retrospective study

Key Points

Abstract

Cite This Study

Also Consider

Also Consider